SCHEMBL4892085

SCHEMBL4892085

C[C@@H]1CNCC[C@@H]1c1ccc(OC(F)(F)F)c(Cl)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR1 P30872 3/20 0.39
SSTR4 P31391 3/20 0.39
S1PR2 O95136 1/20 0.39
GRIN2B Q13224 4/20 0.38
P2RY14 Q15391 1/20 0.38
TACR1 P25103 1/20 0.37
CXCR2 P25025 1/20 0.36
HTR2A P28223 2/20 0.36
HTR1A P08908 1/20 0.36
HTR1D P28221 1/20 0.36
HTR1B P28222 1/20 0.36
HTR1E P28566 1/20 0.36
HTR7 P34969 1/20 0.36
HTR2B P41595 1/20 0.36
HTR3A P46098 1/20 0.36
HTR5A P47898 1/20 0.36
HTR6 P50406 1/20 0.36
CYP2D6 P10635 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4892077 1.00 SSTR1 (0.39) SSTR1SSTR4S1PR2GRIN2BP2RY14
SCHEMBL4892067 1.00 SSTR1 (0.39) SSTR1SSTR4S1PR2GRIN2BP2RY14
SCHEMBL23873247 0.86 SSTR1 (0.39) SSTR1SSTR4P2RY14TACR1HTR2A
SCHEMBL23873360 0.86 SSTR1 (0.39) SSTR1SSTR4P2RY14TACR1HTR2A
SCHEMBL26118250 0.86 SSTR1 (0.39) SSTR1SSTR4P2RY14TACR1HTR2A
SCHEMBL23873361 0.86 SSTR1 (0.39) SSTR1SSTR4P2RY14TACR1HTR2A
SCHEMBL23873250 0.86 SSTR1 (0.39) SSTR1SSTR4P2RY14TACR1HTR2A
SCHEMBL26115646 0.86 SSTR1 (0.39) SSTR1SSTR4P2RY14TACR1HTR2A
SCHEMBL4892063 0.81 SLC6A4 (0.44) HTR2AHTR1AHTR1DHTR1BHTR1E
SCHEMBL4892079 0.81 SLC6A4 (0.44) HTR2AHTR1AHTR1DHTR1BHTR1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080312271-A1 AZABENZIMIDAZOLYL COMPOUNDS PFIZER INC. 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312271-A1 AZABENZIMIDAZOLYL COMPOUNDS AZI2, PAICS, UGT2B7 SSTR1 2295/4885SSTR4 982/4885S1PR2 2454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.